(WAY) Waystar Holding Common - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US9467841055

WAY: Cloud-Based, Software, Healthcare, Payments, Financial,

Waystar Holding Corp. specializes in developing cloud-based software solutions tailored for healthcare payment management. Its platform streamlines financial operations through modules such as financial clearance, patient financial care, and claims management, enhancing efficiency for healthcare providers. The company, established in 2017 and based in Lehi, Utah, serves a broad spectrum of healthcare entities, including hospitals and medical groups.

The platforms capabilities extend to denial prevention, revenue capture, and comprehensive analytics, providing users with actionable insights to optimize their financial workflows. Waystars solutions are designed to integrate with existing healthcare information systems, ensuring seamless data flow and reducing administrative burdens.

Ticker: WAY is listed on the NASDAQ exchange, categorizing under Health Care Technology. With a market capitalization of $4.474 billion, the company reflects substantial market presence despite its relatively recent inception.

From a technical standpoint, WAYs stock exhibits a 20-day average volume of 1,418,050 shares, with a last price of $37.02. The SMA 20, 50, and 200 are $36.59, $38.68, and $32.25, respectively, indicating recent price stability. The ATR of 1.71 suggests moderate volatility.

Fundamentally, WAYs return on equity stands at -0.62, highlighting current profitability challenges. The absence of P/E and P/S metrics may indicate the companys focus on growth over immediate returns, a common strategy in the software sector.

3-Month Forecast: Based on the SMA trends, WAY may face resistance around $38.68, with support near $32.25. The ATR suggests price fluctuations within a $1.71 range. Fundamentally, while the negative RoE raises concerns, the companys market cap and industry position suggest potential for recovery and growth, contingent on improving profitability metrics.

Additional Sources for WAY Stock

WAY Stock Overview

Market Cap in USD 6,827m
Sector Healthcare
Industry Health Information Services
GiC Sub-Industry Health Care Technology
IPO / Inception 2024-06-07

WAY Stock Ratings

Growth Rating 48.3
Fundamental 30.1
Dividend Rating 0.0
Rel. Strength 104
Analysts 4.56/5
Fair Price Momentum 46.55 USD
Fair Price DCF 15.31 USD

WAY Dividends

No Dividends Paid

WAY Growth Ratios

Growth Correlation 3m -68.2%
Growth Correlation 12m 90.9%
Growth Correlation 5y 90.9%
CAGR 5y 96.52%
CAGR/Max DD 5y 4.20
Sharpe Ratio 12m 1.23
Alpha 83.96
Beta 0.885
Volatility 36.36%
Current Volume 2188.3k
Average Volume 20d 1298k
What is the price of WAY stocks?
As of May 05, 2025, the stock is trading at USD 40.68 with a total of 2,188,308 shares traded.
Over the past week, the price has changed by +11.03%, over one month by +16.46%, over three months by -0.93% and over the past year by +96.52%.
Is Waystar Holding Common a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Waystar Holding Common is currently (May 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 30.05 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of WAY as of May 2025 is 46.55. This means that WAY is currently undervalued and has a potential upside of +14.43% (Margin of Safety).
Is WAY a buy, sell or hold?
Waystar Holding Common has received a consensus analysts rating of 4.56. Therefor, it is recommend to buy WAY.
  • Strong Buy: 5
  • Buy: 4
  • Hold: 0
  • Sell: 0
  • Strong Sell: 0
What are the forecast for WAY stock price target?
According to ValueRays Forecast Model, WAY Waystar Holding Common will be worth about 52.9 in May 2026. The stock is currently trading at 40.68. This means that the stock has a potential upside of +30.14%.
Issuer Forecast Upside
Wallstreet Target Price 48.2 18.4%
Analysts Target Price 30.3 -25.6%
ValueRay Target Price 52.9 30.1%